Explore All 542 Buyout (LBO, MBO, MBI) Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 7, 2012 |
| Target | Bioventus |
| Sector | Medical Products |
| Buyer(s) |
Ampersand Capital Partners
EW Healthcare Partners Alta Partners Spindletop Capital Management |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 28 of 86 |
| Sector: Medical Products | 10 of 18 |
| Type: Buyout (LBO, MBO, MBI) | 12 of 23 |
| State: North Carolina | 2 of 3 |
| Country: United States | 28 of 70 |
| Year: 2012 | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-11-01 |
BakoDx
Alpharetta, Georgia, United States BakoDx provides specialty laboratory testing services that offer a comprehensive testing menu, including complete anatomic pathology services, proprietary molecular genetic testing, and peripheral neuropathy immuno-histochemical testing. Bako is based in Alpharetta, Georgia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-09-24 |
Calloway Laboratories
Woburn, Massachusetts, United States Calloway Laboratories, Inc. is a premier provider of specialized clinical toxicology services to support pain management as well as addiction recovery programs. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| Deal Context for Buyer | # |
|---|---|
| Overall | 45 of 59 |
| Sector: Medical Products | 20 of 24 |
| Type: Buyout (LBO, MBO, MBI) | 5 of 7 |
| State: North Carolina | 2 of 3 |
| Country: United States | 40 of 50 |
| Year: 2012 | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-05-01 |
PreCision Dermatology
Cumberland, Rhode Island, United States PreCision Dermatology, Inc. is a specialty pharmaceutical company developing, manufacturing and marketing prescription and consumer dermatology products. Our mission is to develop innovative skincare therapies with proven clinical performance that patients prefer and physicians are confident to prescribe. |
Sell | $85M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-05-10 |
Influence Health
Birmingham, Alabama, United States Influence Health, Inc. is a provider of patient engagement software and healthcare marketing analytics solutions to hospitals across the United States and Canada. The company's software platform helps healthcare organizations attract and retain patients and improves patient experience and care through enhanced patient-doctor communication and information accessibility. |
Buy | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| Deal Context for Buyer | # |
|---|---|
| Overall | 51 of 59 |
| Sector: Medical Products | 6 of 6 |
| Type: Buyout (LBO, MBO, MBI) | 4 of 4 |
| State: North Carolina | 3 of 3 |
| Country: United States | 43 of 50 |
| Year: 2012 | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-02-08 |
ChemoCentryx
San Carlos, California, United States ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally administered therapies. ChemoCentryx was incorporated in 1996 and is headquartered in San Carlos, California. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-10-23 |
ZS Pharma
Coppell, Texas, United States ZS Pharma, founded in 2008, is a privately held specialty pharmaceutical company based in Coppell, Texas and Menlo Park, CA. Our core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2011 |
| Size | Small |
| Type | Sector Focused |
Spindletop Capital Management LLC is an investment firm focused on both regional and national companies from the healthcare sector. The Firm pursues a variety of transaction types, including management buyouts, growth financings, and recapitalizations. Spindletop Capital Management was formed in 2011 and is based in Austin, Texas.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Medical Products | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) | 1 of 2 |
| State: North Carolina | 1 of 1 |
| Country: United States | 1 of 4 |
| Year: 2012 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-23 |
HNI Healthcare
Austin, Texas, United States HNI Healthcare is a provider of tech-enabled hospitalist services. HNI specializes in hospitalist staffing and management services, utilizing its proprietary VitalSigns software platform to more efficiently deliver clinical best practices within hospital-based medicine. HNI Healthcare was founded in 2009 and is based in Austin, Texas. |
Buy | - |
